Log in
Enquire now
‌

US Patent 11866508 Anti-mesothelin binding proteins

Patent 11866508 was granted and assigned to Amgen on January, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Amgen
Amgen
0
Date Filed
January 6, 2021
0
Date of Patent
January 9, 2024
0
Patent Applicant
Amgen
Amgen
0
Patent Application Number
17142850
0
Patent Citations
‌
US Patent 7064244 Transgenic mammals having human Ig loci including plural VH and VK regions and antibodies produced therefrom
0
‌
US Patent 6846634 Method to screen phage display libraries with different ligands
0
‌
US Patent 6881557 Super humanized antibodies
0
‌
US Patent 7029872 Methods for producing modified glycoproteins
0
‌
US Patent 8101722 Less immunogenic binding molecules
0
‌
US Patent 8206710 Anti-mesothelin antibodies
0
‌
US Patent 8236308 Composition comprising cross-species-specific antibodies and uses thereof
0
‌
US Patent 8247194 Preparation of scFv antibody fragments
0
‌
US Patent 8268970 Human antibodies that bind mesothelin, and uses thereof
0
‌
US Patent 8383779 Human antibodies that bind mesothelin, and uses thereof
0
•••
Patent Inventor Names
Carl Kozlosky
0
Jean Gudas
0
William Christian Fanslow, III
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11866508
0
Patent Primary Examiner
‌
Sheela J. Huff
0
CPC Code
‌
A61P 35/00
0
‌
C07K 16/30
0
‌
C07K 2317/31
0
‌
G01N 33/574
0
‌
A61K 2039/505
0

Find more entities like US Patent 11866508 Anti-mesothelin binding proteins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.